Integrated Analysis of CD1A Immune Infiltration and Competing Endogenous RNA Networks in COAD
Houxi Xu,Hongqun Zhang,Songxian Sun,Jingyuan Zhang,Jiege Huo,Chunxiang Zhou
DOI: https://doi.org/10.2147/ijgm.s455546
IF: 2.145
2024-05-11
International Journal of General Medicine
Abstract:Houxi Xu, 1, 2, &ast Hongqun Zhang, 1, 3, &ast Songxian Sun, 2, &ast Jingyuan Zhang, 2 Jiege Huo, 1, 3 Chunxiang Zhou 2 1 Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing, University of Chinese Medicine, Nanjing, People's Republic of China; 2 School of Traditional Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, People's Republic of China; 3 The Third School of Clinical Medicine, Nanjing University of Chinese Medicine, Nanjing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Chunxiang Zhou, School of Traditional Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, People's Republic of China, Email Jiege Huo, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, 210028, People's Republic of China, Email Background: The CD1A gene, a key component of the human immune system and part of the CD1 family, plays a crucial role in presenting lipid antigens to T cells. Abnormal CD1A expression is associated with various immune-related diseases and tumors. However, the biological function of CD1A in COAD is unclear. Methods: Multiple databases were systematically employed to conduct an analysis of CD1A expression in pan-cancer and COAD, along with its clinical-pathological features. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) functional enrichment analyses of CD1A were performed using the 'clusterProfiler' package. The Protein-protein interaction (PPI) analysis of CD1A was used the STRING database. Additionally, TIMER and ssGSEA tools were used to explore the relationship between CD1A expression in COAD and immune cell infiltration. The study also investigated the association between CD1A expression and N6-methyladenosine (m6A) modification genes in the TCGA COAD cohort and constructed a CD1A-centric competing endogenous RNA (ceRNA) regulatory network. Results: CD1A displays varying expression levels in various tumors, including COAD, and is closely linked to clinical-pathological characteristics. GO analysis suggests that CD1A plays a role in important processes like antigen processing and presentation, leukocyte-mediated immunity, and lymphocyte-mediated immunity. KEGG analysis identifies CD1A's involvement in key pathways such as the Chemokine signaling pathway and Cytokine-cytokine receptor interaction. PPI analysis highlights CD1A's interactions with CD207, CD1C, CD1E, FOXP3, and ITGB2. ssGSEA analysis indicates a significant relationship between CD1A expression and the infiltration of various immune cells in COAD. Significant associations were found between CD1A and m6A modification genes in COAD. Furthermore, a CD1A-centered ceRNA regulatory network has been constructed. Conclusion: CD1A emerges as a potential biomarker for the diagnosis and treatment of COAD, showing a strong association with tumor immune infiltration, m6A modification, and the ceRNA network. Keywords: CD1A, COAD, immune infiltration, m6A, ceRNA Colon adenocarcinoma (COAD) is globally recognized as one of the prevalent malignant tumors of the digestive system, with a steadily increasing incidence across various world regions. 1 Research has established a close correlation between the onset of COAD and genetic factors, including family history and hereditary tumor syndromes, as well as lifestyle modifications such as diet and physical activity. 2 Particularly in advanced stages, COAD exhibits high malignancy, often resulting in poor prognoses without prompt treatment, thereby presenting a significant challenge to global public health. Despite advancements in early diagnosis and treatment, the five-year survival rate for advanced-stage colon adenocarcinoma patients remains suboptimal. 3 The pathogenesis of colon adenocarcinoma involves a complex interplay of multiple molecular aspects, including dysregulation of the cell cycle, alterations in signaling pathways like Wnt/β-catenin and PI3K/Akt, and interactions within the tumor microenvironment. 4–7 These intricate mechanisms present significant obstacles to developing effective treatments for colon adenocarcinoma. Therefore, exploring the molecular mechanisms of colon adenocarcinoma and identifying new biomarkers and therapeutic targets are crucial for improving patient outcomes and treatment effectiveness. CD1A is a crucial element of the human immune system, responsible for transporting nonpeptide antigens such as lipids and glycolipids to T cells. 8,9 As a member of the -Abstract Truncated-
medicine, general & internal